Patrys Limited , a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131128005382&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131128005382&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment